Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexplanon insertion timing and breastfeeding outcomes
NCT03978598Phase 4Completed
- Sponsor
- The University of New Mexico
- Start
- Jun 2019
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etonogestrel, sponsored by The University of New Mexico. Primary endpoint: Continuation of Breastfeeding at 8 Weeks Postpartum. Started Jun 2019; status: completed.
02
Drugs
etonogestrel
Beyond the preview
Go deeper on NCT03978598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03978598.